Establishes a generic drug research and development laboratory and production facility and the empire state biosimilar insulin initiative

Establishes a generic drug research and development laboratory and production facility to manufacture generic prescription drugs in the state and the empire state biosimilar insulin initiative, which will develop generic forms of the three most widely used forms of insulin.